Form 4: Ameresco Director Sells Shares Under 10b5-1 Plan

Ameresco Director Nickolas Stavropoulos executed pre-planned sales of Class A Common Stock after exercising stock options.

Summary

• Ameresco Director Nickolas Stavropoulos engaged in transactions involving Class A Common Stock.
• On February 12, 2026, Stavropoulos acquired 200 shares by exercising stock options at $16.33 per share and subsequently sold these 200 shares at $34.00 per share.
• On February 13, 2026, Stavropoulos acquired 245 shares by exercising stock options at $16.33 per share and subsequently sold these 245 shares at a weighted average price of $34.05 per share, with prices ranging from $34.02 to $34.15.
• All sales were conducted under a Rule 10b5-1 trading plan adopted on September 8, 2025.
• Following these transactions, Stavropoulos directly beneficially owns 14,111 shares of Class A Common Stock and 23,455 stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sales were pre-planned under a 10b5-1 plan, indicating a routine diversification or liquidity event rather than a reaction to new company-specific information.

Positives

• The exercise of stock options indicates a realization of value from previously granted equity compensation.
• The sales were executed at prices significantly higher than the exercise price ($34.00 and $34.05 vs. $16.33), indicating a profitable transaction for the director.

Negatives

• The director sold a total of 445 shares of Class A Common Stock, reducing direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under a Rule 10b5-1 plan, are common for executives and directors managing their personal portfolios and liquidity. While sales reduce insider ownership, a pre-planned sale typically carries less negative signaling than an unplanned, open-market sale.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be perceived as a slight negative, though mitigated by the 10b5-1 plan. It does not directly impact company operations or financial health.
• Employees: No direct impact on employees.
• Customers: No direct impact on customers.
• Suppliers: No direct impact on suppliers.
• Creditors: No direct impact on creditors.

Key Dates

Recommendation

The transactions are routine insider sales executed under a pre-planned 10b5-1 trading plan, which typically do not signal a significant change in the company's fundamental outlook. While a reduction in insider ownership can be a minor concern, the pre-planned nature suggests it's for personal financial management rather than a bearish view on the stock. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter the investment thesis.

Keywords

Ameresco, AMRC, Form 4, Insider Trading, Stock Options, Share Sale, 10b5-1 Plan, Director Transactions, Equity Compensation